PDT Partners’s Arcosa ACA Stock Holding History

PDT Partners’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-23,721	Closed	-$2.25M	–	702
2024 Q3	$2.25M	Sell	23,721 -3,724	-14%	-$325K	0.2%	178
2024 Q2	$2.29M	Buy	27,445 +1,716	+7%	+$143K	0.22%	169
2024 Q1	$2.21M	Sell	25,729 -2,519	-9%	-$205K	0.21%	172
2023 Q4	$2.33M	Buy	28,248 +20,252	+253%	+$1.49M	0.26%	119
2023 Q3	$575K	Buy	+7,996	New	+$607K	0.07%	392

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PDT Partners's ACA Position: Q4 2024 in Review

PDT Partners sold out of Arcosa (ACA) in Q4 2024, closing a stake of 23,721 shares — an estimated $2.25M sold.

PDT Partners first reported a position in ACA in Q3 2023 and held it in 5 quarters. The position peaked at $2.33M in Q4 2023. 329 funds tracked by Wall St. Rank hold ACA as of Q4 2024.

PDT Partners reported no remaining Arcosa position as of Q4 2024 after selling out during the quarter.
PDT Partners sold 23,721 Arcosa shares in Q4 2024, an estimated $2.25M.
PDT Partners first reported a position in Arcosa in Q3 2023 and held it in 5 quarters.
PDT Partners's Arcosa position peaked at $2.33M in Q4 2023.
329 funds tracked by Wall St. Rank held Arcosa as of Q4 2024.

Based on PDT Partners's 13F filing for Q4 2024, filed 14 Feb 2025.